Gerstein Fisher - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Gerstein Fisher ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2015$106,000
-32.1%
29,905
-3.8%
0.02%
-34.8%
Q3 2015$156,000
-31.0%
31,102
-11.6%
0.02%
-37.8%
Q2 2015$226,000
-5.0%
35,185
+4.2%
0.04%
-5.1%
Q1 2015$238,000
-7.8%
33,782
+0.6%
0.04%
-7.1%
Q4 2014$258,000
-9.5%
33,586
-12.1%
0.04%
-16.0%
Q3 2014$285,000
-20.2%
38,198
+3.5%
0.05%
-26.5%
Q2 2014$357,000
+16.7%
36,919
+0.2%
0.07%
+11.5%
Q1 2014$306,000
-89.1%
36,853
-42.9%
0.06%
-41.3%
Q4 2013$2,803,000
+990.7%
64,528
+100.0%
0.10%
+85.7%
Q3 2013$257,000
+6.6%
32,264
+3.3%
0.06%
-3.4%
Q2 2013$241,00031,2220.06%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders